Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore

Wednesday, March 15, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

BEIJING, March 15, 2017 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company

focusing on research, development, manufacturing, sales and marketing of immuno-therapeutic products and vaccines, today announced that the company will present at annual BioPharma Asia Convention 2017 at Suntec Convention Center, Singapore.  The presentation
is scheduled for 12:40 PM local time on March 22, 2017.

The management of Yisheng Biopharma will provide its business update on clinical progress of immuno-oncology therapeutics, vaccine products as well as commercialization strategies in Asia, USA and Europe.  

About Yisheng Biopharma Co., Ltd.

Yisheng Biopharma Co., Ltd. is a biopharmaceutical company headquartered in Beijing, China, focusing on the research, development, manufacturing and sales and marketing of immunological and vaccine products, with approximately 1000 employees in China, USA and Singapore. 

www.yishengbio.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/yisheng-biopharma-to-present-at-biopharma-asia-convention-2017-in-singapore-300423941.html

SOURCE Yisheng Biopharma Co., Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook